Understanding Pharmabees ETF: An Overview of Healthcare Sector Exposure
- Why Invest in PHARMABEES ETF?
- Performance Overview
- Top Holdings
- Advantages of Investing in PHARMABEES ETF
- Is PHARMABEES Right for You?
- Why Choose Navia’s Zero Brokerage Stock Investing App to invest in PHARMABEES ETF?
- List of Other PHARMA ETF’s And Their Historical Performance
- How to Invest in PHARMABEES ETF on Navia APP?
- Conclusion
- Frequently Asked Questions
Recent global shifts have underscored the indispensable nature of the healthcare and pharmaceutical sectors, making them more vital than ever. For individuals seeking exposure to the healthcare and pharmaceutical sector, the Nippon India Nifty Pharma ETF (PHARMABEES ETF) provides a strategic entry point. This ETF offers diversified exposure to India’s top pharmaceutical firms, providing exposure to developments in the pharmaceutical and healthcare industry.
Why Invest in PHARMABEES ETF?
The PHARMABEES ETF offers a streamlined way to track the Nifty Pharma Index, providing exposure to leading players in the pharmaceutical industry. By investing in this ETF, investors gain exposure to the healthcare sector represented in the index and the ongoing advancements in medical research and manufacturing.
Performance Overview
The PHARMABEES ETF has reflected the movement of the underlying index, mirroring the movement aligned with the sector’s historical trends of the pharmaceutical industry. The following data provides a clear comparison of the fund’s performance against both its benchmark and the broader category:
| Time Period | Fund Returns (%) | Category Returns (%) |
|---|---|---|
| 6 Months | 3.22 | 3.82 |
| 1 Year | 14.40 | 17.03 |
| 3 Years | 24.85 | 17.97 |
| Since Inception | 11.26 | – |
Mirroring the Nifty Pharma Index’s trajectory, the PHARMABEES ETF has demonstrated a historical performance reflecting the index movement. Its performance underscores a precise alignment with the pharmaceutical sector’s expansion, establishing it as an ETF designed to track the pharmaceutical sector index.
Top Holdings
The PHARMABEES ETF maintains a concentrated exposure to the leaders of India’s healthcare sector. The fund’s primary allocations are dominated by several of the largest and most influential pharmaceutical companies in the country:
| Company | Sector | % of Total Holdings |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | 21.29% |
| Divi’s Laboratories Ltd | Pharmaceuticals | 9.69% |
| Cipla Ltd | Pharmaceuticals | 9.39% |
| Dr. Reddy’s Laboratories Ltd | Pharmaceuticals | 9.36% |
| Lupin Ltd | Pharmaceuticals | 6.58% |
Advantages of Investing in PHARMABEES ETF
Sectoral Diversification
Instead of betting on a single pharma company; where a failed clinical trial or a regulatory audit could crash into the stock, PHARMABEES gives you a basket of the top 20 pharmaceutical companies. This minimizes “unsystematic risk” and provides exposure to the broader healthcare sector represented in the index.
Cost Efficiency
Managing a portfolio of 20 stocks involves significant brokerage and transaction costs. Since PHARMABEES is an ETF, it has a much lower Expense Ratio compared to actively managed pharma mutual funds. Lower costs may help investors reduce overall investment expenses over time.
Hedging Against Market Volatility
The pharmaceutical sector is traditionally considered a defensive sector. In a slowing economy or a bear market, people still need medicine and healthcare. Consequently, pharmaceutical companies are sometimes categorized as part of defensive sectors due to the essential nature of healthcare services.
High Liquidity and Transparency
Because it is traded on the NSE like a regular stock, you can buy or sell units of PHARMABEES at any time during market hours. The underlying holdings are published daily, providing a level of transparency that allows you to know exactly what you own.
Exposure to the “Global Pharmacy” Theme
Indian pharmaceutical companies are major suppliers of generic drugs and vaccines worldwide. By investing in this ETF, you are tapping into India’s competitive advantage in global healthcare manufacturing and R&D.
Is PHARMABEES Right for You?
For individuals seeking sector-specific exposure to healthcare, the PHARMABEES ETF serves as a sector-focused exchange-traded fund. By combining sector growth trends with broad diversification and low-cost efficiency, it offers a versatile solution for long-term investors with varying investment approaches from shifting healthcare trends.
Why Choose Navia’s Zero Brokerage Stock Investing App to invest in PHARMABEES ETF?
Choosing PHARMABEES ETF via Navia’s platform provides a powerful combination of sector-specific growth and cost-efficiency. The zero-brokerage structure may help reduce transaction costs for investors.
🔸 Cost Savings: Zero brokerage ensures that investors save on transaction costs, helping lower trading costs.
🔸 User-Friendly Interface: Navia’s app is designed to be intuitive and easy to use, making the investment process seamless.
🔸 Easy Stock/ETF SIP Baskets: Easily create a stock/ETF basket of your choice and start an SIP.
🔸 24/7 Accessibility: Investors can manage their investments anytime, anywhere, providing convenience and flexibility.
List of Other PHARMA ETF’s And Their Historical Performance
Note: As on 27 February 2026
| ETF Name | 30 Day Return | 365 Day Return |
|---|---|---|
| PHARMABEES | 5.81% | 11.08% |
| MOHEALTH (Motilal Oswal S&P BSE Healthcare ETF) | 6.91% | 11.83% |
| HEALTHADD (DSP Nifty Healthcare ETF) | 7.20% | 14.43% |
| HEALTHY (Aditya Birla Sun Life Nifty Healthcare ETF) | 7.20% | 14.33% |
How to Invest in PHARMABEES ETF on Navia APP?
1. Download and Log in to the Navia app.
2. Go to Tools->Basket and create a Basket with name of your choice. After creating the basket name, click on the Proceed to Add Items button.
3. It opens a page there you can add PHARMABEES to the basket and select the quantity and price. Then click on the Add Symbol option. Market price is most preferable if you are setting up a SIP.
4. After adding it to Basket, click on the SIP Order option to confirm and Activate the SIP.
5. Enter Frequency, Installment and Weekly SIP Day, then agree to the Terms & Conditions, then click on the Activate SIP option.
6. You can always Pause the SIP when needed. You can also edit the Stock Price and QTY in the SIP by using the Edit option.
With zero brokerage, setting up a SIP on the Navia app is cost-effective and hassle-free, making it an excellent option for long-term investors. Navia also provides FREE Ready-made ETF basket for hassle-free SIP investment on selected TOP ETF’s.
Conclusion
The Nippon India Nifty Pharma ETF (PHARMABEES ETF) provides an exposure to companies within India’s healthcare sector. By tracking top-tier pharmaceutical companies, this ETF offers a balance of historical performance based on available market data and targeted sector exposure, making it an one of the available investment instruments for those looking to gain exposure to India’s pharmaceutical manufacturing sector.
Securing a position in this resilient industry allows you to participate in a sector driven by consistent global and domestic demand. By integrating PHARMABEES into your portfolio today, you can align your long-term financial goals with the growth of one of India’s most innovative sectors.
Explore the PHARMABEES ETF and investors may explore this ETF after evaluating their investment objectives!
Do You Find This Interesting?
We’d Love to Hear from you-
Frequently Asked Questions
Is Pharmabees a good investment?
The Nippon India Nifty Pharma ETF (PHARMABEES ETF) serves as a an option for gaining sector exposure aiming to tap into the evolving healthcare landscape. By combining a track record of historical performance based on market data with a portfolio of high-conviction holdings, this ETF provides a streamlined, sector-focused vehicle to provide exposure to long-term sector trends of India’s pharmaceutical industry.
Is pharma ETF a good investment?
While a pharma ETF provides a cost-efficient gateway to India’s healthcare giants, its performance is closely tied to shifting industry trends, regulatory hurdles, and global export demand. Investors should note that because this is a thematic fund, it carries higher concentration risk and susceptibility to policy changes compared to diversified indices.
What is the purpose of pharmabees?
The Nippon India Nifty Pharma ETF is designed to provide investors with a streamlined, cost-effective way to capture the performance of the entire pharmaceutical industry through one diversified asset.
What are the risks of investing in pharma ETFs?
Regulatory Roadblocks: Stringent industry oversight means that drug application rejections or policy shifts can instantly devalue specific holdings and the overall ETF.
Clinical trial risk: The sector depends on R&D success; if a key drug fails to meet its primary endpoints during trials, the resulting stock price crash will drag down ETF performance.
Patent cliff risk: When patents on blockbuster drugs expire, generic competition floods the market, leading to sharp revenue declines for major companies within the fund.
Concentration risk: Despite being a basket of stocks, these ETFs are sector specific. If the fund is heavily weighted toward a few giant firms, their individual setbacks will disproportionately impact your returns.
Are ETFs riskier than stocks?
Exchange-traded funds (ETFs) generally offer a lower risk profile than individual securities by providing immediate, built-in diversification. To optimize a portfolio, you can use a “core and satellite” approach: utilize ETFs to stabilize your foundation through broad market exposure, while strategically adding individual stocks and bonds to chase higher potential returns or specific income goals.
DISCLAIMER: Investments in the securities market are subject to market risks, read all the related documents carefully before investing. The securities quoted are exemplary and are not recommendatory. Brokerage will not exceed the SEBI prescribed limit.
